Clinical Trial Update: Postmarketing Study to Determine Performance of the SIGMA HP® PARTIAL KNEE SYSTEM [Phase 4]

View source ↗

Summary

Phase 4 postmarketing study to evaluate the performance of the SIGMA HP Partial Knee System. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Osteoarthritis
• Post-traumatic Arthritis
• Pseudo-gout

Drugs mentioned

• SIGMA HP Partial Knee System

Snippet

Sponsor: DePuy International | Conditions: Osteoarthritis, Post-traumatic Arthritis | Phase 4 | Status: COMPLETED